One similar company to compare MindMed’s potential future PPS to is Compass Pathways who hover around USD $55.00. There is a difference in outstanding shares however at this embryonic phase of such a pioneering, upcoming space, no need to pay too much attention to that (Tilray hit $300.00 say no more).